30 November 2002
Predicting the Grade of Banff 97 Classification of Chronic Allograft Nephropathy Based on Examination of Graft Dysfunction (a Preliminary Report)
O Schück, O Viklický, L Voska, S Vítko, V Teplan, J Lácha, A Jabor, J Skibová, M ŠtollováAnn Transplant 2003; 8(3): 5-7 :: ID: 7519
Abstract
Objectives: Progression of chronic allograft nephropathy (CAN) is associated with a progressive decrease in graft function. Prediction of the Banff CAN grade on the basis of correlation between the grade of histological changes and Scr is difficult because of the big spread of individual values. This study sought to predict the Banff CAN grade based on Scr, Ccr and proteinuria using ROC analysis. Methods: Graft protocol biopsy and functional testing (Scr, Ccr and proteinuria) were performed in 77 subjects (43 men, 34 women, mean age 48.4±12.8 years) at 33.8±1.0 months after their first renal transplantation. Immunosuppression was provided with the triple combination of cyclosporin A, prednisone and azathioprine (or mycophenolate mofetil). Statistical evaluation was performed using receiver-operating curve (ROC) analysis. The cut-off value of the Banff CAN score was set at 1. Results: The mean values and SD of the investigated functional parameters in study subjects were as follows: Scr = 201.5 (±100.0) µmol/l Ccr = 48.1 (±21.2) ml/min/1.73 m2, proteinuria = 0.89 (±1.96) g/24 h. ROC analysis showed the highest AUC (±SEM) for Scr 0.806 (±0.063). The respective values were 0.790 (±0.053) for Ccr and 0.643 (±0.075) for proteinuria. The AUC (area under the ROC curve) for Scr was significantly higher (P275 µmol/l and Ccr
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






